U.S. flag

An official website of the United States government

NM_000352.6(ABCC8):c.4411G>A (p.Asp1471Asn) AND Hyperinsulinemic hypoglycemia, familial, 1

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Aug 16, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000169299.9

Allele description [Variation Report for NM_000352.6(ABCC8):c.4411G>A (p.Asp1471Asn)]

NM_000352.6(ABCC8):c.4411G>A (p.Asp1471Asn)

Gene:
ABCC8:ATP binding cassette subfamily C member 8 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.1
Genomic location:
Preferred name:
NM_000352.6(ABCC8):c.4411G>A (p.Asp1471Asn)
Other names:
NM_000352.6(ABCC8):c.4411G>A; p.Asp1471Asn
HGVS:
  • NC_000011.10:g.17395172C>T
  • NG_008867.1:g.86731G>A
  • NM_000352.6:c.4411G>AMANE SELECT
  • NM_001287174.3:c.4414G>A
  • NM_001351295.2:c.4477G>A
  • NM_001351296.2:c.4411G>A
  • NM_001351297.2:c.4408G>A
  • NP_000343.2:p.Asp1471Asn
  • NP_001274103.1:p.Asp1472Asn
  • NP_001338224.1:p.Asp1493Asn
  • NP_001338225.1:p.Asp1471Asn
  • NP_001338226.1:p.Asp1470Asn
  • LRG_790t1:c.4411G>A
  • LRG_790t2:c.4414G>A
  • LRG_790:g.86731G>A
  • LRG_790p1:p.Asp1471Asn
  • LRG_790p2:p.Asp1472Asn
  • NC_000011.9:g.17416719C>T
  • NM_000352.3:c.4411G>A
  • NM_000352.4:c.4411G>A
  • NM_000352.5:c.4411G>A
  • NR_147094.2:n.4706G>A
Protein change:
D1470N
Links:
dbSNP: rs72559716
NCBI 1000 Genomes Browser:
rs72559716
Molecular consequence:
  • NM_000352.6:c.4411G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001287174.3:c.4414G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351295.2:c.4477G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351296.2:c.4411G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351297.2:c.4408G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_147094.2:n.4706G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hyperinsulinemic hypoglycemia, familial, 1 (HHF1)
Synonyms:
HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS; HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY; NESIDIOBLASTOSIS OF PANCREAS; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009734; MedGen: C2931832; Orphanet: 276575; Orphanet: 276598; OMIM: 256450

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000220618Counsyl
criteria provided, single submitter

(Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015))
Likely pathogenic
(Aug 21, 2014)
unknownliterature only

PubMed (8)
[See all records that cite these PMIDs]

Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015),

Citation Link,

SCV000914500Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 09 May 2019)
Pathogenic
(Nov 1, 2018)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Citation Link,

SCV004026579Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Aug 16, 2023)
germlinecuration

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Familial hyperinsulinism and pancreatic beta-cell ATP-sensitive potassium channels.

Sharma N, Crane A, Gonzalez G, Bryan J, Aguilar-Bryan L.

Kidney Int. 2000 Mar;57(3):803-8. Review.

PubMed [citation]
PMID:
10720932

Functional hot spots in human ATP-binding cassette transporter nucleotide binding domains.

Kelly L, Fukushima H, Karchin R, Gow JM, Chinn LW, Pieper U, Segal MR, Kroetz DL, Sali A.

Protein Sci. 2010 Nov;19(11):2110-21. doi: 10.1002/pro.491.

PubMed [citation]
PMID:
20799350
PMCID:
PMC3005782
See all PubMed Citations (12)

Details of each submission

From Counsyl, SCV000220618.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (8)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Illumina Laboratory Services, Illumina, SCV000914500.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (9)

Description

Across a selection of the available literature, the ABCC8 c.4411G>A (p.Asp1471Asn) missense variant, also referred to as c.4414G>A (p. Asp1472Asn), has been identified in12 individuals with hyperinsulinism, six in a compound heterozygous state and six in a heterozygous state (Giurgea et al. 2004; Henwood et al. 2005; Greer et al. 2007; Muzyamba et al. 2007; Brunetti-Pierri et al. 2008; Bellanné-Chantelot et al. 2009; Chandran et al. 2013; Kapoor et al. 2013; Xu et al. 2018). Muzyamba et al. (2007) reported a child with hyperinsulinism and focal disease who is heterozygous for two variants inherited from his father (p.Gly228Asp and p.Asp1471Asn) and one from his mother. The p.Gly228Asp and p.Asp1471Asn variants led to intracellular retention of the channel complex and loss of function, though it is unclear if one of these variants contributed to the loss of function alone. The p.Asp1471Asn variant was absent from 548 controls and is reported at a frequency of 0.00002 in the total population of the Genome Aggregation Database. Based on the collective evidence, the p.Asp1471Asn variant is classified as pathogenic for ABCC8-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, SCV004026579.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (2)

Description

The p.Asp1471Asn variant in ABCC8 has been reported in at least 6 individuals with hyperinsulinemic hypoglycemia (PMID: 20685672, 30186238, 18988933, 24616771, 14764815, 17378627), and has been identified in 0.007% (1/13984) of East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs72559716). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID#: 188931) and has been interpreted as pathogenic or likely pathogenic by multiple sources. Of the 6 affected individuals, 4 were compound heterozygotes that carried a reported pathogenic variant in trans, which increases the likelihood that the p.Asp1471Asn variant is pathogenic (Variation ID: 996301; PMID: 30186238, 18988933, 14764815, 17378627). In vitro functional studies provide some evidence that the p.Asp1471Asn variant may slightly impact protein function (PMID: 17466004). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. One additional pathogenic variant, resulting in a different amino acid change at the same position, p.Asp1471His, has been reported in association with disease in ClinVar, supporting that a change at this position may not be tolerated (Variation ID: 1452717). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive hyperinsulinemic hypoglycemia. ACMG/AMP Criteria applied: PM3_very-strong, PM5, PP3, PS3_supporting, PP2_supporting (Richards 2015).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024